Feasibility study of S-1 as additional therapy after neo-adjuvant or adjuvant chemotherapy for triple negative breast cancer(SBCCSG-14).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2014
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 05 Jun 2009 New trial record.